You have 9 free searches left this month | for more free features.

Leukemia, Myeloid, Acute

Showing 51 - 75 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Allogeneic Hematopoietic Stem Cell Transplantation, Acute Myeloid Leukemia, Myelodysplastic Syndrome Trial in Suzhou

Recruiting
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • +2 more
  • VEN+AZA+Modified BUCY
  • Suzhou, Jiangsu, China
    The First Affiliated Hospital of Soochow University
Apr 10, 2023

Acute Myeloid Leukemia, Acute Myeloid Leukemia Recurrent, Leukemia Trial in Boston (Cytokine-Induced Memory-like Natural Killer

Not yet recruiting
  • Acute Myeloid Leukemia
  • +3 more
  • Cytokine-Induced Memory-like Natural Killer Cells
  • +2 more
  • Boston, Massachusetts
  • +1 more
Nov 22, 2023

Acute Myeloid Leukemia, Myelodysplastic Syndrome With Excess Blasts-2 Trial in Boston (BXCL701)

Not yet recruiting
  • Acute Myeloid Leukemia
  • Myelodysplastic Syndrome With Excess Blasts-2
  • Boston, Massachusetts
    Dana Farber Cancer Institute
Jan 26, 2023

AML, Adult, Minimal Residual Disease Trial in Tianjin (CD33/CLL1 dual CAR-NK cell, Cyclophosphamid, Fludarabine)

Not yet recruiting
  • AML, Adult
  • Minimal Residual Disease
  • CD33/CLL1 dual CAR-NK cell
  • +5 more
  • Tianjin, China
    Institute of Hematology & Blood Diseases Hospital
Aug 4, 2023

Acute Myeloid Leukemia Trial in Memphis (Venetoclax, Azacitidine, Cytarabine)

Not yet recruiting
  • Acute Myeloid Leukemia
  • Memphis, Tennessee
    St. Jude Children's Research Hospital
Jul 21, 2023

Acute Myeloid Leukemia Trial in Suzhou (Venetoclax Oral Tablet, Daunorubicin)

Recruiting
  • Acute Myeloid Leukemia
  • Suzhou, Jiangsu, China
  • +1 more
Jul 3, 2023

Acute Myeloid Leukemia Trial in Houston (Azacitidine, Venetoclax, NK Cells)

Not yet recruiting
  • Acute Myeloid Leukemia
  • Houston, Texas
    M.D. Anderson Cancer Center
Apr 17, 2023

Acute Myeloid Leukemia Trial in Valencia (AFM28)

Recruiting
  • Acute Myeloid Leukemia
  • Valencia, Spain
    Hospital Universitari i Politècnic La Fe
Apr 5, 2023

Acute Myeloid Leukemia Trial in United States (Standard Leukemia Care, Palliative Care)

Active, not recruiting
  • Acute Myeloid Leukemia
  • Standard Leukemia Care
  • Palliative Care
  • Boston, Massachusetts
  • +3 more
Jan 24, 2023

Myelofibrosis, Chronic Myelomonocytic Leukemia, Acute Myeloid Leukemia Trial in Charlottesville (Tagraxofusp)

Recruiting
  • Myelofibrosis
  • +2 more
  • Charlottesville, Virginia
    Danyelle Coley
Jan 18, 2023

Leukemia, Myeloid, Acute Trial in Baltimore (Flotetuzumab)

Not yet recruiting
  • Leukemia, Myeloid, Acute
  • Baltimore, Maryland
    Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Aug 16, 2022

Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Recurrent Acute Myeloid Leukemia, Refractory Acute

Active, not recruiting
  • Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome
  • +2 more
  • Duarte, California
    City of Hope Medical Center
Jan 4, 2023

Acute Myeloid Leukemia Trial in Beijing, Tianjin (LCAR-AMDR Cells Product)

Recruiting
  • Acute Myeloid Leukemia
  • LCAR-AMDR Cells Product
  • Beijing, Beijing, China
  • +1 more
Jan 28, 2023

Acute Myeloid Leukemia, Myelodysplastic Syndrome, Recurrent Acute Myeloid Leukemia Trial in Houston (Decitabine, Quizartinib,

Recruiting
  • Acute Myeloid Leukemia
  • +4 more
  • Houston, Texas
    M D Anderson Cancer Center
Jan 27, 2023

Leukemia Trial in California City, Chicago, Houston (GDX012, Chemotherapy Agents)

Not yet recruiting
  • Leukemia
  • California City, California
  • +2 more
May 24, 2023

Acute Myeloid Leukemia and Myelodysplastic Syndrome Trial in Tianjin (QLF32101)

Not yet recruiting
  • Acute Myeloid Leukemia and Myelodysplastic Syndrome
  • Tianjin, Tianjin, China
    Institute of Hematology&Blood Diseases Hospital,Chinese Academy
Jan 27, 2023

Acute Myeloid Leukemia Trial in Beijing (Azacytidine;Cytarabine;Aclacinomycin;Chidamide;Venetoclax;Granulocyte

Recruiting
  • Acute Myeloid Leukemia
  • Azacytidine;Cytarabine;Aclacinomycin;Chidamide;Venetoclax;Granulocyte colony-stimulating factor
  • "3+7"
  • Beijing, Beijing, China
    Chinese PLA General Hospital
Sep 29, 2023

Leukemia, Myeloid, Acute Trial in Guanzhou (Azacitidine, Venetoclax)

Not yet recruiting
  • Leukemia, Myeloid, Acute
  • Guanzhou, Guandong, China
    Nanfang Hospital of Southern Medical University
Jul 22, 2022

Leukemia, Myeloid, Acute Trial (Cytarabine, Venetoclax, CPX-351)

Not yet recruiting
  • Leukemia, Myeloid, Acute
  • (no location specified)
Nov 25, 2022

Acute Myeloid Leukemia Trial in Tianjin (Different induction chemo regimens)

Not yet recruiting
  • Acute Myeloid Leukemia
  • Different induction chemotherapy regimens
  • Tianjin, China
    Institute of Hematology & Blood Diseases Hospital
Sep 27, 2023

Acute Myeloid Leukemia Trial in Ramat Gan (CAR-T CD19)

Recruiting
  • Acute Myeloid Leukemia
  • CAR-T CD19
  • Ramat Gan, Israel
    Chaim Sheba Medical Center
Oct 30, 2022

Acute Myeloid Leukemia At Initial Diagnosis and/or Relapse in

Not yet recruiting
  • Acute Myeloid Leukemia
  • Genetic Predisposition to Disease
  • Collection of blood sample of bone marrow (cohort 1)
  • Collection of blood sample of bone marrow (cohort 2 and 3)
  • (no location specified)
Mar 6, 2023

Acute Myeloid Leukaemia Trial (SAR445419, fludarabine, cytarabine)

Not yet recruiting
  • Acute Myeloid Leukaemia
  • (no location specified)
Feb 2, 2023

Refractory Acute Myeloid Leukemia, Relapsed Acute Myeloid Leukemia, Acute Myeloid Leukemia Trial in United States

Recruiting
  • Refractory Acute Myeloid Leukemia
  • +4 more
  • CD371-YSNVZ-IL18 CAR T cells
  • Basking Ridge, New Jersey
  • +6 more
Aug 29, 2023

Acute Myeloid Leukemia Trial in Suzhou (Azacitidine Combined With Venetoclax and ATRA group)

Recruiting
  • Acute Myeloid Leukemia
  • Azacitidine Combined With Venetoclax and ATRA group
  • Suzhou, China
    the First Affiliated Hospital of Soochow University
Dec 8, 2022